155 related articles for article (PubMed ID: 38395945)
1. Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc-ODC1 nexus.
Zhang H; Li X; Liu Z; Lin Z; Huang K; Wang Y; Chen Y; Liao L; Wu L; Xie Z; Hou J; Zhang X; Liu H
Cancer Metab; 2024 Feb; 12(1):7. PubMed ID: 38395945
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells.
Zeng Z; Lan J; Lei S; Yang Y; He Z; Xue Y; Chen T
Onco Targets Ther; 2020; 13():11697-11709. PubMed ID: 33244237
[TBL] [Abstract][Full Text] [Related]
3. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
4. ODC1 promotes proliferation and mobility via the AKT/GSK3β/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma.
Ye Z; Zeng Z; Shen Y; Yang Q; Chen D; Chen Z; Shen S
Onco Targets Ther; 2019; 12():4081-4092. PubMed ID: 31239700
[No Abstract] [Full Text] [Related]
5. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ_0003028 regulates cell development through modulating miR-498/ornithine decarboxylase 1 axis in hepatocellular carcinoma.
Zhang T; Sun Q; Shen C; Qian Y
Anticancer Drugs; 2023 Apr; 34(4):507-518. PubMed ID: 36730287
[TBL] [Abstract][Full Text] [Related]
7. HIGD1A inactivated by DNA hypermethylation promotes invasion of kidney renal clear cell carcinoma.
Li L; Zhao J; Zhang H; Li D; Wu S; Xu W; Pan X; Hu W; Chu J; Luo W; Li P; Zhou X
Pathol Res Pract; 2023 May; 245():154463. PubMed ID: 37086631
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
9. HIG1 domain family member 1A is a crucial regulator of disorders associated with hypoxia.
Jia YZ; Liu J; Wang GQ; Pan H; Huang TZ; Liu R; Zhang Y
Mitochondrion; 2023 Mar; 69():171-182. PubMed ID: 36804467
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
11. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q
Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361
[TBL] [Abstract][Full Text] [Related]
12. miR-375 down-regulation of the rearranged L-myc fusion and hypoxia-induced gene domain protein 1A genes and effects on Sertoli cell proliferation.
Guo J; Liu X; Yang Y; Liang M; Bai C; Zhao Z; Sun B
Asian-Australas J Anim Sci; 2018 Aug; 31(8):1103-1109. PubMed ID: 29514449
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma.
Huang Y; Tao Y; Hu K; Lin F; Li X; Feng T; Wang ZM
Tumour Biol; 2016 Nov; 37(11):14903-14914. PubMed ID: 27644248
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine tuning polyamine synthesis.
Liu N; Zhang T; Steer CJ; Song G
Cell Biosci; 2022 Dec; 12(1):192. PubMed ID: 36457036
[TBL] [Abstract][Full Text] [Related]
17. The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics.
Zhu Y; Piao C; Zhang Z; Jiang Y; Kong C
Genomics; 2022 Jan; 114(1):125-137. PubMed ID: 34843906
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
20. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
